Research & Development
ApoB testing may reveal patients at risk of heart disease missed by cholesterol tests: study
In the study, investigators looked at electronic medical records for patients who had ApoB and standard lipid profiles tested within 90 days of each other from 2010 to early 2022.
March 6, 2023
Heart problems more likely among long COVID patients in comprehensive study
In the study, investigators found that individuals who experienced long COVID had more than double the risk of developing new cardiovascular symptoms.
February 23, 2023
Measuring NT-proBNP changes over time may improve risk stratification for heart patients
Measuring the changes in the heart hormone precursor N-terminal-pro hormone BNP over time may improve risk stratification and health outcomes for heart patients.
February 8, 2023
Sepsis increases heart failure, rehospitalization risks following hospital discharge
Hospital patients who initially had or developed sepsis were at higher risk for heart failure, rehospitalization, or death within 12 years than patients without sepsis.
February 1, 2023
Jana Care, Roche to develop blood-testing platform for chronic kidney and heart disease
The platform would enable patients to self-administer critical blood tests at home, and allow clinicians to review the test results remotely.
January 31, 2023
Cardiovascular disease deaths undergo largest single-year increase since 2015
Age-adjusted mortality rates also increased for the first time in many years, by a substantial 4.6%, indicating a global situation in which people of all ages were impacted by the COVID-19 pandemic, especially before vaccines became available.
January 25, 2023
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition
Cue Health Q4 revenues decline 24% as firm expands, diversifies POC test menu
Prevencio obtains Medicare pricing for three AI-enabled cardiac blood tests
The payment rates went into effect on January 1 with Current Procedural Terminology (CPT) billing codes.
January 11, 2023
Daxor announces results of study showing benefits of blood test for measuring blood volume in heart failure
The study showed a consistent lack of correlation between pulmonary artery diastolic pressure and total blood volume, highlighting the need for accurate volume measurement to provide a complete assessment in guiding clinical management decisions.
January 3, 2023
Natera supports guideline proposing donor-derived cfDNA testing for heart transplant surveillance
The International Society for Heart and Lung Transplantation proposes monitoring for rejection with noninvasive biomarkers or biopsy monthly during the first six months post-transplant, as well as testing in the ninth and 12th months post-transplant.
December 23, 2022
Study reveals biomarkers associated with immune checkpoint inhibitor myocarditis
Myocarditis during cancer treatment with an immune checkpoint inhibitor (ICI) was associated with increased levels of three biomarkers implicated in skeletal muscle damage.
December 21, 2022
QuidelOrtho nabs Health Canada approval for high-sensitivity troponin I test on small-footprint analyzer
The test, a fluorescence immunoassay, runs on the Quidel Triage MeterPro platform and provides a quantitative determination of troponin I in whole blood or plasma specimens as an aid in the diagnosis of myocardial infarction.
December 20, 2022
Clinical-grade wearables developer Cardiosense raises $15.1M in Series A financing
The Chicago-based digital health company is leveraging artificial intelligence and multisensor devices to develop tools that enable the early detection of cardiovascular disease.
December 8, 2022
Page 1 of 5